Executive Oncology ECDL: Early Clinical Development Lead

Regulatory Jobs; Upper Providence (Delaware County); Hybrid; USD 284,000 - 474,000; Full time

Benefits offered by this job

Annual bonus

Long-term incentive program

Health care

Retirement benefits

Paid holidays

Vacation

Parental leave

Caregiver leave

Job summary

GSK is seeking a senior Oncology Clinical Development leader to bridge clinical development with translational research, leading a team of Medical Directors and Scientists in early-phase trials. You will design and execute CDPs, manage translational strategies, and interact with regulators, investigators, and cross-functional partners.

This hybrid role requires MD or equivalent with lung cancer expertise, strong leadership, and experience in regulatory submissions.

Qualifications

• MD or equivalent medical degree required.
• Clinical and research experience in lung cancer.
• Experience designing and executing early phase clinical studies.

Responsibilities

• Lead and mentor Oncology Early Clinical Development Medical Directors and Clinical Scientists.
• Own and drive CDP and translational strategy.
• Ensure studies comply with GCP and regulatory requirements.
• Lead regulatory filings sections (IND/NDA).
• Collaborate with cross-functional teams across Oncology.

Skills

Clinical Data Interpretation

Clinical Trial Designs

Clinical Trials Monitoring

Digital Fluency

Drug Development

Drug Regulatory Affairs

Evidence Based Decision Making

Executive Presence

Hematology and Oncology

Learning Agility

Matrix Leadership

Real World Evidence

Scientific Presentations

Strategic Direction

Education

MD or equivalent medical degree

PhD (preferred)

Job description

GSK is seeking a senior Oncology Clinical Development leader to bridge clinical development with translational research, leading a team of Medical Directors and Scientists in early-phase trials. You will design and execute CDPs, manage translational strategies, and interact with regulators, investigators, and cross-functional partners.

This hybrid role requires MD or equivalent with lung cancer expertise, strong leadership, and experience in regulatory submissions.